跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 90,650 条关于
“relapsed/refractory B cell lymphoma”
全部
90,650
临床试验
66,061
药物
6,572
机构
3,225
资讯
14,792
3年前
Genmab and AbbVie Submit Regulatory Applications for Epcoritamab Bispecific Antibody in Relapsed/Refractory B-Cell Lymphomas
去年
Epcoritamab Demonstrates Durable 3-Year Remissions in Relapsed/Refractory Large B-Cell Lymphoma
3年前
Anbalcabtagene Autoleucel Shows 84% Response Rate in Relapsed/Refractory Large B-Cell Lymphoma
去年
Three-Year Data Shows Sustained Benefits of CAR T-Cell Therapy in Relapsed/Refractory Large B-Cell Lymphoma
11个月前
CNS Bridging Radiotherapy Shows Acceptable Safety Profile Prior to CAR-T in B-Cell Lymphoma
5年前
Bispecific CAR-T Therapy Targeting CD19/CD20 Shows Promise in Relapsed B-Cell Lymphoma
去年
FDA Expands Adcetris Approval for Relapsed Large B-Cell Lymphoma Treatment
3年前
FDA Approves Two Bispecific T-Cell Engagers for Relapsed/Refractory B-Cell Lymphomas
去年
ViroCell Biologics Partners with AvenCell Therapeutics to Advance Dual-Targeted Allogeneic CAR-T Therapy
去年
Yescarta Shows Sustained Efficacy in Relapsed/Refractory Large B-Cell Lymphoma
第 1 页，共 1480 页
上一页
下一页
